Reimar Krieg

Title: Reimar Krieg: Innovator in Pharmaceutical Chemistry

Introduction

Reimar Krieg is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for treating infectious diseases.

Latest Patents

One of Reimar Krieg's latest patents is titled "Derivatives of steroid benzylamines, having an antiparasitic antibacterial, antimycotic and/or antiviral action." This invention relates to compounds derived from steroids of a specific general formula, which are utilized in medicine for the prophylaxis and treatment of infectious diseases. The patent also describes pharmaceutical compositions that contain at least one of these compounds, along with methods for synthesizing them. Another significant patent is for "11.beta.-substituted 16.alpha., 17.alpha.-methylene-estra-4,9-dien-3-ones," which includes compounds where R.sup.1 is a methyl or ethyl group.

Career Highlights

Reimar Krieg has worked with prominent organizations in the pharmaceutical sector. He has been associated with Schering Aktiengesellschaft, a leading pharmaceutical company, and Jüstus-Liebig-Universität Giessen, where he contributed to research and development efforts. His work has been instrumental in advancing the understanding and application of steroid derivatives in medicine.

Collaborations

Throughout his career, Reimar has collaborated with esteemed colleagues, including Helmut Kasch and Anatoil Kurischko. These partnerships have fostered innovation and have been crucial in the development of his patented compounds.

Conclusion

Reimar Krieg's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patents reflect a commitment to advancing medical treatments and improving health outcomes. His work continues to influence the development of new therapeutic agents.